NICOLE MARTIN: Open Payments
NPI 1013662840 · PANDORA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,763 in 95 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $306 · 2025 $1,763
Food & beverage: $1,763
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $269 |
| AstraZeneca Pharmaceuticals LP | 11 | $251 |
| ABBVIE INC. | 16 | $222 |
| Lilly USA, LLC | 10 | $199 |
| Otsuka America Pharmaceutical, Inc. | 9 | $170 |
| Axsome Therapeutics, Inc. | 4 | $145 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $105 |
| Abbott Laboratories | 4 | $76 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $69 |
| Boston Scientific Corporation | 2 | $62 |
Products named: VRAYLAR, REXULTI, MOUNJARO, FARXIGA, Ozempic, AIRSUPRA, Auvelity, CAPLYTA.
Industry payments across OH — which companies pay providers there.
